SLC5A2 and hydrops fetalis: Furthermore, considering HF therapies, SGLT2-i users had a more frequent prescription of renin–angiotensin–aldosterone system inhibitors (RAAS-i), statins and diuretics (including both loop and thiazides) at the admission.